Immune Pharmaceuticals Inc.
IMNP
IMNP was delisted on the 25th of July, 2018.
11 hedge funds and large institutions have $227K invested in Immune Pharmaceuticals Inc. in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
7% less capital invested
Capital invested by funds: $243K → $227K (-$16K)
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$164 |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$24.2K |
| 2 |
LPL Financial
San Diego,
California
|
-$10K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$1.39K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$742 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $86K | – | – | – |
|
|
SCM
2
Sio Capital Management
New York
| $79K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $39K | – | – | – |
|
|
EEG
4
E.E. Geduld
| $10K | – | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| $6K | -$1.39K | -178 | -19% |
|
|
IFS
6
Ifrah Financial Services
Little Rock,
Arkansas
| $5K | – | – | – |
|
|
BFA
7
BlackRock Fund Advisors
San Francisco,
California
| $2K | -$24.2K | -3,105 | -91% |
|
|
8
LPL Financial
San Diego,
California
| – | -$10K | -1,000 | Closed |
|
|
BIM
9
BlackRock Investment Management
Wilmington,
Delaware
| – | -$1K | -162 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$742 | -95 | Closed |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$8 | +1 | New |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | +$164 | +21 | New |
|
IMNP Hedge Fund Activity: Q2 2016 in Review
11 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immune Pharmaceuticals Inc. (IMNP) for Q2 2016, worth a combined $227K — down 6.6% from $243K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IMNP and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Bank of America, opening a new position worth an estimated $164. The largest seller was BlackRock Fund Advisors, cutting an estimated $24.2K.
- 11 institutional investors held Immune Pharmaceuticals Inc. (IMNP) as of Q2 2016, down from 13 in Q1 2016.
- Funds reported $227K of Immune Pharmaceuticals Inc. stock for Q2 2016, down 6.6% quarter-over-quarter.
- 2 funds opened new Immune Pharmaceuticals Inc. positions in Q2 2016 and 4 closed out, a net change of -2 holders.
- The largest Immune Pharmaceuticals Inc. buyer in Q2 2016 was Bank of America, an estimated $164 added.
- The largest Immune Pharmaceuticals Inc. seller in Q2 2016 was BlackRock Fund Advisors, an estimated $24.2K sold.
Based on aggregated 13F filings for Q2 2016.